In addition, mutations in TP53 occur as early truncal events in tumor evolution and allow tolerance of a greater degree of genomic instability, resulting subclonal diversification and intra‐tumor,25, 26 which correlated with aggressively biological behaviors and higher tumor mutation burden (TMB). This evidence concerns the gene TP53 and neoplasm.